ES423963A1 - Heterocyclic compounds - Google Patents
Heterocyclic compoundsInfo
- Publication number
- ES423963A1 ES423963A1 ES423963A ES423963A ES423963A1 ES 423963 A1 ES423963 A1 ES 423963A1 ES 423963 A ES423963 A ES 423963A ES 423963 A ES423963 A ES 423963A ES 423963 A1 ES423963 A1 ES 423963A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- substituted
- choice
- groups
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Procedure to prepare derivatives of 6-substituted-aminopenicyllanic and cephalosporanic acids, with the general formulas: **(See formula)** where Q represents the group **(See formula)** where U represents an amido group (eg saccharyl, succinimido or phthalamido) or a group OE' where E' represents hydrogen, a salt-forming cation, a steric residue such as a (lower) alkyl group substituted by choice with a (lower) alkanoyloxy group which can also be substituted, a silyl group, a phenacyl group, a benzyl group, a benzohydryl group, a trichlorethyl group, or tert-butyl group, x represents a hydrogen atom, a hydroxy group , a (lower) alkanoyloxy (preferably acetoxy) group or residue of a nucleophilic agent, such as a halogen atom, an acid group; a cyano group, and carbamoyloxy group, a choice substituted heterocyclic mononuclear group containing a sulfur or nitrogen atom (eg, pyridinyl); an -S-Q' group (where Q' represents a diazolyl, triazolyl, tetrazolyl, thiazolyl, thiadiazolyl, triatriazolyl, oxazolyl, oxadiazolyl, benzimidazolyl, benzoxazolyl, triazol-pyridinyl or puridinyl group), or X represents an amino group where Q represents a group with the formula XX; R1 represents a lower alkyl group (eg methyl, ethyl, propyl, osopropyl, butyl, sec.butyl, isobutyl, t-butyl) optionally substituted in primary or secondary position with 1 fluorine, chlorine atom, a group hydroxy, or lower alkoxy (eg fluoromethyl, 2-chloroethyl, methoxymethyl, 1-hydroxyethyl) or a cycloalkyl group optionally substituted with 1 or more lower alkyl groups, hydroxy or lower alkoxy groups or where R1 represents an adamantyl group or a phenyl group substituted by choice with a maximum of 3 of the substituents selected from chlorine, fluorine, hydroxy, lower alkoxy and lower alkyl, or where R1 represents a five-membered mononuclear heterocyclic group, (for example, furyl, thienyl, isoxazolyl, isothiazolyl, oxadiazolyl) substituted by choice with lower alkyl groups, or where represents an aralkyl group (for example, benzyl) substituted by choice in the phenyl nucleus as mentioned above , ou n carboxymethyl group, and represents, together with the definition indicated above for R1, a hydrogen atom, a (lower) alkyl group optionally substituted with a chlorine or fluorine atom, a (lower) alkoxy group, a cycloalkyl group, a phenyl group, which in turn is substituted by choice with a maximum of three of the aforementioned substituents, or Z1'' represents a carboxy group esterified with a residue of (lower) alkyl, phenyl, cycloalkyl or aralkyl, being at choice said phenyl radicals substituted with a maximum of one of the aforementioned substituents, or represents an N-substituted carbamoyl group of choice with one or two lower alkyl groups, a phenyl group, a five-membered mononuclear heterocyclic group, a cycloalkyl group , one or two arylalkyl (lower) or cycloalkylalkyl (lower) groups, with the phenyl and cycloalkyl groups being substituted with a maximum of one of the substituents a Indicated above, o represents a carbamoyl group having its nitrogen atom as a member of a heterocyclic ring (eg morpholino) and where R2 represents a group **(See formula)** where n represents O, 1, 2 or 3, and R3 represents a hydrogen atom or a lower alkyl group, and R4 represents a hydrogen atom, a lower alkyl, a cycloalkyl, phenyl or aralkyl group, or R4 represents a group -COOE, where E represents a hydrogen atom or a salt-forming group (when n &g; 1), or a residue of (lower) alkyl, benzyl or phenyl ester, or R4 represents a carbamoyl group N- optionally substituted with one or two and (lower) alkyl, or alkenyl groups, a phenyl group, a cycloalkyl group, one or two arialkyl (lower) or cycloalkylalkyl (lower) groups, with the phenyl and cycloalkyl groups being substituted with a maximum of one of the aforementioned substituents, or where R3 and R4, together with the carbon atom to which they are attached, represent a substituted cycloalkyl group of choice, and Z4 represents a hydrogen atom or a substituted aryl group of choice comprising react an acid with the s general formulas: **(See formula)** in which (see graph) are as previously defined for R1 and Z1 or represent groups that can easily become those that fall within the definition of R1 and Z''1 and that can be influenced or can also react under reaction conditions employed (eg protected amino, hydroxy and carboxy groups), or **(See formula)** where (see graph) are as defined above for R2 and Z4 or represent groups that can easily become those that fall within the definition of R2 and Z4 and that can be influenced or react under reaction conditions as well, or **(See formula)** where (see graph) are as previously defined for Z2 and Z3 or represent groups that can easily become those that fall within the definition of Z2 and Z3 and that can also be influenced or react under reaction conditions, with an intermediate phosphazo prepared in situ, obtained by the reaction of phosphorous trichloride and an amine salt or a compound according to the formulas: **(See formula)** in the presence of an exactly predetermined excess of amine used, under anhydrous conditions, followed by separation, isolation or both of the obtained compound and the removal of the protecting groups present at choice in order to form the corresponding free penicillanic or cephalosporic acid, and transform at choice these acids in their salts or esters. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5952472A GB1459392A (en) | 1972-12-22 | 1972-12-22 | Heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES423963A1 true ES423963A1 (en) | 1976-07-01 |
Family
ID=10483917
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES421726A Expired ES421726A1 (en) | 1972-12-22 | 1973-12-21 | Heterocyclic compounds |
ES423963A Expired ES423963A1 (en) | 1972-12-22 | 1974-03-06 | Heterocyclic compounds |
ES423962A Expired ES423962A1 (en) | 1972-12-22 | 1974-03-06 | Heterocyclic compounds |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES421726A Expired ES421726A1 (en) | 1972-12-22 | 1973-12-21 | Heterocyclic compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES423962A Expired ES423962A1 (en) | 1972-12-22 | 1974-03-06 | Heterocyclic compounds |
Country Status (10)
Country | Link |
---|---|
JP (3) | JPS4994695A (en) |
AT (1) | AT344318B (en) |
BE (1) | BE809037A (en) |
DE (2) | DE2365705A1 (en) |
ES (3) | ES421726A1 (en) |
FR (2) | FR2211232B1 (en) |
GB (1) | GB1459392A (en) |
HU (1) | HU167924B (en) |
NL (2) | NL162654C (en) |
SE (3) | SE7611134L (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3905893A (en) * | 1973-08-22 | 1975-09-16 | Gulf Research Development Co | Plural stage residue hydrodesulfurization process |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1364453A (en) * | 1970-11-06 | 1974-08-21 | Gist Brocades Nv | Penicillanic and cepholosporanic acid derivatives |
-
1972
- 1972-12-22 GB GB5952472A patent/GB1459392A/en not_active Expired
-
1973
- 1973-12-19 FR FR7345508A patent/FR2211232B1/fr not_active Expired
- 1973-12-20 NL NL7317432.A patent/NL162654C/en active
- 1973-12-21 ES ES421726A patent/ES421726A1/en not_active Expired
- 1973-12-21 JP JP48143379A patent/JPS4994695A/ja active Pending
- 1973-12-21 BE BE139223A patent/BE809037A/en unknown
- 1973-12-21 DE DE2365705A patent/DE2365705A1/en active Pending
- 1973-12-21 AT AT1072573A patent/AT344318B/en not_active IP Right Cessation
- 1973-12-21 DE DE2364129A patent/DE2364129A1/en not_active Withdrawn
- 1973-12-21 HU HUGI197A patent/HU167924B/hu unknown
-
1974
- 1974-03-06 ES ES423963A patent/ES423963A1/en not_active Expired
- 1974-03-06 ES ES423962A patent/ES423962A1/en not_active Expired
-
1976
- 1976-01-02 FR FR7600026A patent/FR2289171A1/en not_active Withdrawn
- 1976-10-07 SE SE7611134A patent/SE7611134L/en unknown
- 1976-10-07 SE SE7611135A patent/SE7611135L/en unknown
-
1977
- 1977-11-30 JP JP14377477A patent/JPS5373565A/en active Pending
- 1977-11-30 JP JP14377377A patent/JPS5377088A/en active Pending
-
1978
- 1978-06-30 NL NL7807076A patent/NL7807076A/en not_active Application Discontinuation
-
1979
- 1979-07-03 SE SE7905814A patent/SE7905814L/en unknown
Also Published As
Publication number | Publication date |
---|---|
NL7317432A (en) | 1974-06-25 |
JPS5377088A (en) | 1978-07-08 |
ES421726A1 (en) | 1976-04-16 |
DE2364129A1 (en) | 1974-07-25 |
BE809037A (en) | 1974-06-21 |
FR2289171A1 (en) | 1976-05-28 |
GB1459392A (en) | 1976-12-22 |
NL162654C (en) | 1980-06-16 |
ATA1072573A (en) | 1977-11-15 |
SE7905814L (en) | 1979-07-03 |
SE7611134L (en) | 1976-10-07 |
AT344318B (en) | 1978-07-10 |
ES423962A1 (en) | 1976-07-01 |
NL162654B (en) | 1980-01-15 |
JPS4994695A (en) | 1974-09-09 |
FR2211232A1 (en) | 1974-07-19 |
FR2211232B1 (en) | 1978-01-13 |
NL7807076A (en) | 1978-10-31 |
DE2365705A1 (en) | 1976-01-15 |
JPS5373565A (en) | 1978-06-30 |
SE7611135L (en) | 1976-10-07 |
HU167924B (en) | 1976-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3363244D1 (en) | Compounds, process for their preparation and their use as pharmaceutical preparations | |
ES8607244A1 (en) | Use of quinoline derivatives for the protection of cultivated plants. | |
NL7505375A (en) | NEW PENICILLIN AND CEPHALOSPORIN DERIVATIVES AND METHOD FOR PREPARING THEM. | |
ATE14579T1 (en) | PHARMACEUTICAL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM. | |
ES474229A1 (en) | New derivatives of 4-phenyl-2-(2',2',2-trichlorethoxycarboxamido)-thiazole useful as medicaments, pharmaceutical compositions containing them and process for the preparation of these compounds. | |
ES8200685A1 (en) | 3-optionally substituted methyl-2- penem derivatives | |
GB1459065A (en) | Therapeutic thiophene derivatives | |
GB1053085A (en) | ||
GB1505885A (en) | Substituted cephalosporins | |
ES423963A1 (en) | Heterocyclic compounds | |
ES373715A1 (en) | Acylation of 6-aminopenicillanic acid and 7-aminocephalosporanic acid | |
ES8203867A1 (en) | Benzothiazole derivatives, pharmaceutical compositions containing them and process for their preparation. | |
ES479570A1 (en) | 7 alpha -Methoxycephalosporin derivatives and their pharmaceutical compositions having antibacterial activity | |
ES463783A1 (en) | Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them | |
IE41219B1 (en) | Aralkyl esters of aminoalkanoic acids | |
ES469182A1 (en) | Antibacterial agents | |
ES270557A1 (en) | Procedure for the preparation of new derivatives of the alquilbenzoico acid (Machine-translation by Google Translate, not legally binding) | |
ES8200372A1 (en) | Cephalosporin derivatives and process for their preparation and pharmaceutical compositions containing them. | |
ES444441A1 (en) | A procedure for the preparation of new cephalosporins. (Machine-translation by Google Translate, not legally binding) | |
ES430905A1 (en) | Tetrazole coumarin derivatives | |
DE2963724D1 (en) | Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them | |
ES483889A1 (en) | Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them. | |
ES227433A3 (en) | New procedure for obtaining aminoalkylphenoatiazine. (Machine-translation by Google Translate, not legally binding) | |
JPS5283679A (en) | Pirazine derivative | |
ES8105325A1 (en) | Penicillanic acid derivatives, their preparation and their pharmaceutical compositions with a penicillin or cephalosporin. |